Skip to main content
. 2022 Nov 16;16:3775–3783. doi: 10.2147/OPTH.S379373

Table 3.

Comparison of PPCT and SFCT Between CRVO and BRVO

CRVO n=26 BRVO n=45 P
PPCT
 Affected-eye (µm)
  Baseline 155.38±48.23 116.84±51.30 0.017*
  3 months 132.34±52.64 114.52±52.34 0.408
  9 months 151.84±61.61 113.17±53.76 0.017*
Fellow-eye (µm)
  Baseline 144.50±59.71 106.77±48.03 0.014*
  3 months 136.72±58.37 113.00±50.88 0.192
  9 months 162.13±59.85 109.69±50.43 0.001*
SFCT
Affected-eye (µm)
  Baseline 273.16±60.99 232.00±77.49 0.129
  3 months 251.65±74.50 220.62±77.51 0.402
  9 months 246.47±69.45 222.93±82.17 0.073
Fellow-eye (µm)
  Baseline 248.05±82.80 205.62±82.41 0.099
  3 months 236.39±86.23 213.70±67.67 0.405
  9 months 259.75±85.09 201.74±84.86 0.011*

Notes: Comparisons between CRVO and BRVO evaluated through ANCOVA (values presented were corrected for age). *p <0.05: statistically significant.

Abbreviations: CRVO, central retinal vein occlusion; BRVO, branch retinal vein occlusion; PPCT, peripapillary choroidal thickness; SFCT, subfoveal choroidal thickness.